Bariatric surgery's long-term outlook is murky, caught between competing visions...
Psychiatrists — and other physicians — should be compensated for time spent resp...
Questions about ProMED's future persist, as striking moderators face a new deadl...
The federal government has started penalizing Medicare Advantage insurers for fa...
Just like in many other parts of the country, Long Islanders are having a tough ...
Explore the revolutionary Monoblock systems by Capmatic, where innovation meets ...
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...
Following public outcry and a government investigation, Allina Health has renege...
Lutetium (lu177) lilotomab satetraxetan is under clinical development by Thor Me...
Specialised Therapeutics has entered into a licensing agreement with Treeway for...
Pharmaceutical firm Phebra has reached a new six-year collaboration agreement wi...
Novartis division Sandoz has concluded the acquisition of global brand rights fo...
The Janssen has submitted a sBLA to the US FDA for RYBREVANT plus chemotherapy f...
GC Biopharma has signed a memorandum of understanding (MOU) with Eubiologics to ...
